Publication
Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.
Tanja C van Dijk, Marcel Smid, Debbie G J Robbrecht, Khrystany T Isebia, John W M Martens, Nick Beije
European journal of cancer (Oxford, England : 1990)Oct 5, 2026PMID 42623835doi:10.1016/j.ejca.2026.116992 Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 17, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260917-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
INTRODUCTION: Survival in metastatic castration-resistant prostate cancer (mCRPC) patients remains limited and treatment is complicated by tumor heterogeneity. As antibody-based therapeutics emerge, identifying actionable antigen targets and patient subgroups most likely to benefit is…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Prostate Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.